Katherine Lajkosz

2.1k total citations
96 papers, 1.1k citations indexed

About

Katherine Lajkosz is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cancer Research. According to data from OpenAlex, Katherine Lajkosz has authored 96 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 33 papers in Surgery and 15 papers in Cancer Research. Recurrent topics in Katherine Lajkosz's work include Prostate Cancer Treatment and Research (26 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Bladder and Urothelial Cancer Treatments (12 papers). Katherine Lajkosz is often cited by papers focused on Prostate Cancer Treatment and Research (26 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Bladder and Urothelial Cancer Treatments (12 papers). Katherine Lajkosz collaborates with scholars based in Canada, United States and Portugal. Katherine Lajkosz's co-authors include Susan B. Brogly, Ana Johnson, Darrin Payne, R. Scott McClure, Stephen F. Hall, M. Diane Lougheed, David Barber, Sulaiman Nanji, Don Thiwanka Wijeratne and Stephen L. Archer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Katherine Lajkosz

79 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Lajkosz Canada 18 531 288 243 200 120 96 1.1k
Ioannis Kaklamanos Greece 17 504 0.9× 557 1.9× 85 0.3× 162 0.8× 63 0.5× 49 1.2k
Philippe Caillet France 21 357 0.7× 276 1.0× 82 0.3× 190 0.9× 76 0.6× 80 1.6k
Julia B. Finkelstein United States 15 205 0.4× 191 0.7× 89 0.4× 134 0.7× 121 1.0× 49 744
Liam C. Macleod United States 18 357 0.7× 374 1.3× 40 0.2× 185 0.9× 70 0.6× 54 968
Okan Erdoğan Türkiye 18 237 0.4× 319 1.1× 385 1.6× 221 1.1× 51 0.4× 107 1.2k
C. Mertens France 12 513 1.0× 336 1.2× 107 0.4× 210 1.1× 43 0.4× 43 1.9k
Benjamin Nutter United States 21 149 0.3× 515 1.8× 154 0.6× 59 0.3× 102 0.8× 53 1.3k
Mari S. Oba Japan 19 348 0.7× 324 1.1× 135 0.6× 76 0.4× 85 0.7× 103 1.3k
David I. Chu United States 17 365 0.7× 307 1.1× 70 0.3× 105 0.5× 397 3.3× 74 995
Jennifer Bruny United States 16 210 0.4× 682 2.4× 173 0.7× 54 0.3× 85 0.7× 44 1.1k

Countries citing papers authored by Katherine Lajkosz

Since Specialization
Citations

This map shows the geographic impact of Katherine Lajkosz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Lajkosz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Lajkosz more than expected).

Fields of papers citing papers by Katherine Lajkosz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Lajkosz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Lajkosz. The network helps show where Katherine Lajkosz may publish in the future.

Co-authorship network of co-authors of Katherine Lajkosz

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Lajkosz. A scholar is included among the top collaborators of Katherine Lajkosz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Lajkosz. Katherine Lajkosz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lajkosz, Katherine, et al.. (2026). Statin use and outcomes in advanced prostate cancer:Secondary analysis of the SPARTAN trial. Urologic Oncology Seminars and Original Investigations. 110992–110992.
2.
Lajkosz, Katherine, et al.. (2024). Statin use and oncological outcomes in a propensity-matched cohort of nonmetastatic castration resistant prostate cancer patients of the ARAMIS trial. Urologic Oncology Seminars and Original Investigations. 43(3). 193.e7–193.e17. 1 indexed citations
3.
4.
5.
Ghai, Sangeet, Antonio Finelli, Katherine Lajkosz, et al.. (2024). MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial. Radiology. 310(3). e231473–e231473. 10 indexed citations
6.
7.
Lajkosz, Katherine, et al.. (2024). Computed tomography identifies sex-specific differences in surgical chronic thromboembolic pulmonary hypertension. SHILAP Revista de lepidopterología. 6. 100130–100130. 3 indexed citations
8.
Bernardino, Rui, Katherine Lajkosz, Marian S. Wettstein, et al.. (2024). Undetected Cribriform and Intraductal Prostate Cancer at biopsy is associated with adverse outcomes. Prostate Cancer and Prostatic Diseases. 28(1). 187–192. 3 indexed citations
9.
Prendeville, Susan, Harpreet Kaur, Tracy Stockley, et al.. (2024). Somatic Tumor Testing in Prostate Cancer: Experience of a Tertiary Care Center Including Pathologist-Driven Reflex Testing of Localized Tumors at Diagnosis. Modern Pathology. 37(6). 100489–100489.
10.
11.
Toma, Augustin, et al.. (2023). The use of machine learning models to predict PFS and OS outcomes from waterfall plots in randomized clinical trials (MAP-OUTCOMES).. JCO Global Oncology. 9(Supplement_1). 107–107. 3 indexed citations
12.
Lajkosz, Katherine, Esther Masih‐Khan, Donna Reece, et al.. (2023). The Impact of CD34+ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 23(11). 850–856. 2 indexed citations
13.
Lajkosz, Katherine, et al.. (2023). Quantitative and qualitative impact of physician assistants in a Canadian urology setting. Canadian Urological Association Journal. 17(10). 337–340. 2 indexed citations
14.
Ghai, Sangeet, Nathan Perlis, Katherine Lajkosz, et al.. (2022). Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. Radiology. 305(2). 390–398. 22 indexed citations
15.
Perlis, Nathan, Antonio Finelli, Katherine Lajkosz, et al.. (2022). Exploring the value of using patient-oriented MRI reports in clinical practice — a pilot study. Supportive Care in Cancer. 30(8). 6857–6876. 1 indexed citations
16.
Fleshner, Neil, Aaron R. Hansen, Joseph L. Chin, et al.. (2022). Randomized phase II trial of neoadjuvant abiraterone plus or minus cabazitaxel in high-risk prostate cancer: ACDC-RP.. Journal of Clinical Oncology. 40(6_suppl). 224–224. 4 indexed citations
17.
Shiff, Benjamin, Udi Blankstein, Keith Jarvi, et al.. (2021). The impact of cannabis use on male sexual function: A 10-year, single-center experience. Canadian Urological Association Journal. 15(12). E652–E657. 10 indexed citations
18.
Herrera‐Cáceres, Jaime O., Katherine Lajkosz, Hanan Goldberg, et al.. (2020). Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes. European Urology Open Science. 21. 1–4. 1 indexed citations
19.
Lajkosz, Katherine, et al.. (2019). Patterns of Referral for Fertility Preservation Among Female Adolescents and Young Adults with Breast Cancer: A Population-Based Study. Journal of Adolescent and Young Adult Oncology. 8(2). 197–204. 29 indexed citations
20.
Merchant, Shaila J., Susan B. Brogly, Christopher M. Booth, et al.. (2018). Palliative Care is Associated with Reduced Aggressive End-of-Life Care in Patients with Gastrointestinal Cancer. Annals of Surgical Oncology. 25(6). 1478–1487. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis Kaklamanos Breakdown of academic impact, for papers by Philippe Caillet Breakdown of academic impact, for papers by Julia B. Finkelstein Breakdown of academic impact, for papers by Liam C. Macleod Breakdown of academic impact, for papers by Okan Erdoğan Breakdown of academic impact, for papers by C. Mertens Breakdown of academic impact, for papers by Benjamin Nutter Breakdown of academic impact, for papers by Mari S. Oba Breakdown of academic impact, for papers by David I. Chu Breakdown of academic impact, for papers by Jennifer Bruny
Rankless by CCL
2026